Research & Development

Name of the Study
Oms721 -Omeros
Tarrant Nephrology
March 2018 to
April 2017 to Ongoing
Tarrant Dialysis
Lock It 100 – CorMedix
March 2017 to Ongoing
Tarrant Nephrology
pMonofer – Parexell
Life West – Zoll
Tarrant Nephrology
Feb 2017 to August 2017
Acthar Gel – Xcinta
Tarrant Nephrology
Jan 2016 to June 2017
AVeNEW -Bard
Tarrant Vascular
August 2016 to Ongoing
AVeVA -Bard
Tarrant Vascular
August 2016 to Ongoing
Lutonix -Bard
Tarrant Vascular
June 2015 to Ongoing
Prospective cross-over analysis of Dimesol dialyzer
Tarrant Nephrology
Oct 2015 to March 2016
Centros Flo prospective multicenter study
Tarrant Nephrology
Feb 2014 to March 2015
Predictors of cephalic arch stenosis
Tarrant Nephrology
Nov 2014 to Oct 2015
Access flow and Cardiovascular Outcomes
Angiocare Tucson
March 2012 to Feb 2013
RESCUE Trial: Multicenter randomized double blinded case control study – stent vs PTA for bare metal in-stent stenosis in hemodialysis
Angiocare Tucson
June 2013 to August 2014
Split-tip vs symmetric tip catheter
Angiocar, Tucson (case control)
June 2012 to Feb 2013
Optimization of access flow through inflow banding
Angiocare, Tucson (Prospective analysis)
Feb 2012 to Feb 2013
Renin vein sampling in non-occlusive
Angiocare, Tucson (Retrospective)
May 2012 to Jan 2013

Role of PACAP in cisplatin-induced AKI In mice models:

Invitro (HK2 cells) and invivo studies in mice models (Dr.Batuman)

Mechanisms of Light Chain induced proximal Tubule damage:

Invitro (HK2) cells (Dr.Batuman)

Renoprotective effects of statins in light chain Induced AKI models:

Invitro (HK2) cells

Role of RAAS blockade in chronic kidney Disease:

Review and Meta-Analysis

Regeneration of renal cells using omental Tissue

Basic Research at Heakton Institute of Medical Research (Dr.Singh)

Decreased urinary peptide excretion in patients with renal failure:

The Heakton Institute of Medical and Cook County Hospital, Chicago (Dr.Ashok Singh)

Beta-blockers in diabetic hypertensive Patients:

Meta-analysis of randomized trials